BAY 94-9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results

Shadan Lalezari, Mark T. Reding, Ingrid Pabinger, Pal Andre Holme, Claude Negrier, Pavani Chalasani, Ho Jin Shin, Maria Wang, Despina Tseneklidou-Stoeter, Monika Maas Enriquez

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'BAY 94-9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results'. Together they form a unique fingerprint.

Medicine & Life Sciences